Revvity Inc. (RVTY) To Go Ex-Dividend on July 17th

Revvity Inc. (NYSE:RVTY) announced a quarterly dividend on Thursday, April 30th. Stockholders of record on Friday, July 17th will be paid a dividend of 0.07 per share on Friday, August 7th. This represents a c) annualized dividend and a dividend yield of 0.3%. The ex-dividend date is Friday, July 17th.

Revvity has a payout ratio of 5.1% meaning its dividend is sufficiently covered by earnings. Analysts expect Revvity to earn $5.78 per share next year, which means the company should continue to be able to cover its $0.28 annual dividend with an expected future payout ratio of 4.8%.

Revvity Trading Up 0.1%

RVTY stock opened at $111.24 on Wednesday. The firm has a fifty day moving average price of $102.88 and a 200 day moving average price of $98.87. Revvity has a fifty-two week low of $81.22 and a fifty-two week high of $118.30. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.41 and a current ratio of 1.72. The firm has a market cap of $12.41 billion, a PE ratio of 53.23, a price-to-earnings-growth ratio of 2.43 and a beta of 1.09.

Revvity (NYSE:RVTY) last announced its quarterly earnings results on Tuesday, May 5th. The company reported $1.06 earnings per share for the quarter, topping the consensus estimate of $1.02 by $0.04. Revvity had a net margin of 8.26% and a return on equity of 8.00%. The company had revenue of $711.12 million for the quarter, compared to analysts’ expectations of $704.07 million. During the same quarter in the previous year, the business posted $1.01 earnings per share. Revvity’s quarterly revenue was up 7.0% on a year-over-year basis. Revvity has set its FY 2026 guidance at 5.200-5.300 EPS. Sell-side analysts anticipate that Revvity will post 5.25 earnings per share for the current fiscal year.

Revvity Company Profile

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.